GB0427379D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0427379D0
GB0427379D0 GBGB0427379.3A GB0427379A GB0427379D0 GB 0427379 D0 GB0427379 D0 GB 0427379D0 GB 0427379 A GB0427379 A GB 0427379A GB 0427379 D0 GB0427379 D0 GB 0427379D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0427379.3A
Other versions
GB2421240A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB0427379A priority Critical patent/GB2421240A/en
Publication of GB0427379D0 publication Critical patent/GB0427379D0/en
Priority to ARP050100478A priority patent/AR047541A1/en
Priority to PCT/EP2005/001378 priority patent/WO2005080358A2/en
Priority to AU2005215880A priority patent/AU2005215880A1/en
Priority to EP05707330A priority patent/EP1735291A2/en
Priority to JP2006552554A priority patent/JP2007522172A/en
Priority to US10/588,614 priority patent/US20080319024A1/en
Priority to CA002554888A priority patent/CA2554888A1/en
Publication of GB2421240A publication Critical patent/GB2421240A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
GB0427379A 2004-02-13 2004-12-14 Phosphoric acid salt of rosiglitazone Withdrawn GB2421240A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB0427379A GB2421240A (en) 2004-12-14 2004-12-14 Phosphoric acid salt of rosiglitazone
ARP050100478A AR047541A1 (en) 2004-02-13 2005-02-10 PHOSPHATE OF 5 - [[4- [2-METHYL-2-PYRIDINYL-AMINO-ETOXI] PHENYL] METHYL] -2,4 THYZOLIDINADION (ROSIGLITAZONE) AND ITS POLYMORPHIC FORMS
PCT/EP2005/001378 WO2005080358A2 (en) 2004-02-13 2005-02-11 Rosiglitazone phosphate and polymorphic forms
AU2005215880A AU2005215880A1 (en) 2004-02-13 2005-02-11 Rosiglitazone phosphate and polymorphic forms
EP05707330A EP1735291A2 (en) 2004-02-13 2005-02-11 Rosiglitazone phosphate and polymorphic forms
JP2006552554A JP2007522172A (en) 2004-02-13 2005-02-11 Rosiglitazone phosphate and polymorphic forms
US10/588,614 US20080319024A1 (en) 2004-02-13 2005-02-11 Rosiglitazone Phosphate and Polymorphic Forms
CA002554888A CA2554888A1 (en) 2004-02-13 2005-02-11 Rosiglitazone phosphate and polymorphic forms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0427379A GB2421240A (en) 2004-12-14 2004-12-14 Phosphoric acid salt of rosiglitazone

Publications (2)

Publication Number Publication Date
GB0427379D0 true GB0427379D0 (en) 2005-01-19
GB2421240A GB2421240A (en) 2006-06-21

Family

ID=34090026

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0427379A Withdrawn GB2421240A (en) 2004-02-13 2004-12-14 Phosphoric acid salt of rosiglitazone

Country Status (1)

Country Link
GB (1) GB2421240A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate

Also Published As

Publication number Publication date
GB2421240A (en) 2006-06-21

Similar Documents

Publication Publication Date Title
GB0410712D0 (en) Organic compounds
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0405900D0 (en) Organic compounds
GB0406738D0 (en) Organic compounds
GB0403964D0 (en) Organic compounds
GB0402682D0 (en) Organic compounds
GB0402100D0 (en) Organic compounds
GB0424279D0 (en) Organic compounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)